These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29126900)

  • 1. Activity of nucleic acid polymers in rodent models of HBV infection.
    Schöneweis K; Motter N; Roppert PL; Lu M; Wang B; Roehl I; Glebe D; Yang D; Morrey JD; Roggendorf M; Vaillant A
    Antiviral Res; 2018 Jan; 149():26-33. PubMed ID: 29126900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection.
    Vaillant A
    ACS Infect Dis; 2019 May; 5(5):675-687. PubMed ID: 30199230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.
    Blanchet M; Sinnathamby V; Vaillant A; Labonté P
    Antiviral Res; 2019 Apr; 164():97-105. PubMed ID: 30771404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.
    Boulon R; Blanchet M; Lemasson M; Vaillant A; Labonté P
    Antiviral Res; 2020 Nov; 183():104853. PubMed ID: 32585322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2022 Aug; 6(8):1870-1880. PubMed ID: 35368148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
    Beilstein F; Blanchet M; Vaillant A; Sureau C
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.
    Real CI; Werner M; Paul A; Gerken G; Schlaak JF; Vaillant A; Broering R
    Sci Rep; 2017 Mar; 7():43838. PubMed ID: 28272460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
    Guillot C; Martel N; Berby F; Bordes I; Hantz O; Blanchet M; Sureau C; Vaillant A; Chemin I
    PLoS One; 2017; 12(6):e0179697. PubMed ID: 28636622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.
    Al-Mahtab M; Bazinet M; Vaillant A
    PLoS One; 2016; 11(6):e0156667. PubMed ID: 27257978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
    Noordeen F; Scougall CA; Grosse A; Qiao Q; Ajilian BB; Reaiche-Miller G; Finnie J; Werner M; Broering R; Schlaak JF; Vaillant A; Jilbert AR
    PLoS One; 2015; 10(11):e0140909. PubMed ID: 26560490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection.
    Usman Z; Mijočević H; Karimzadeh H; Däumer M; Al-Mathab M; Bazinet M; Frishman D; Vaillant A; Roggendorf M
    J Viral Hepat; 2019 Dec; 26(12):1454-1464. PubMed ID: 31323705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
    Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
    Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.
    Lu M; Lohrengel B; Hilken G; Kemper T; Roggendorf M
    J Virol; 2002 Jan; 76(1):58-67. PubMed ID: 11739671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.